Effectiveness of Clinical Pharmacist Interventions in Optimizing Pharmacotherapy for Somatic Comorbidities in Serious Mental Illness: A Clinical Audit

Overview

Journal Explor Res Clin Soc Pharm

Date 2024 Mar 8

PMID 38455672

Authors

Diamantis Klimentidis

Affiliations

Soon will be listed here.

Abstract

Background: Clinical pharmacists significantly improve pharmacotherapy outcomes. Patients with serious mental illness (SMI) represent a group particularly vulnerable to medication mismanagement, potentially benefiting from pharmaceutical care targeting medication appropriateness.

Objective: This study aimed to assess the prevalence of inappropriate medication for somatic comorbidities in SMI patients and to evaluate the impact of clinical pharmacist-led interventions.

Methods: A pre-post intervention audit involving clinical pharmacist intervention was conducted on SMI patients with somatic comorbidities in a psychiatric clinic in Greece. A comprehensive medication review was undertaken by a clinical pharmacist. The Medicines Appropriateness Index (MAI) and Assessment of Underutilization of medication (AOU) instruments were used to gauge pharmacotherapy appropriateness before and after intervention. Physician acceptance rates and clinical significance were also noted. Statistical analysis employed descriptive and inferential methods, with a significance level set at α = 0.05.

Results: A total of 58 patients were reviewed. Most patients (75.86%) were being inappropriately treated at baseline, versus 15.52% post-intervention. The pharmacist proposed 107 interventions of which 104 (97.2%) were physician-accepted. Changes in MAI and AOU identified improved medication appropriateness post-intervention [χ = 33.029, < 0.005]. Pharmacist interventions resulted in more (52.1%, = 25), less (16.7%, = 8) and no changes (31.2%, = 15) in the total number of prescribed medicines [median difference:1, < 0.005]. From 49 medication initiation recommendations, the most prescribed medicines were statins for primary or secondary prevention ( = 21, 42.8%), aspirin for primary or secondary prevention ( = 9, 18.36%) and metformin ( = 4, 8.2%).

Conclusion: SMI patients had a high prevalence of physical comorbidities, mainly cardiovascular disease, and a high ratio of inappropriate medication treatment. Intervention by a clinical pharmacist significantly improved medication appropriateness and led to the adoption of a new standard of care, to be checked with re-auditing.

References

Somers A, Robays H, De Paepe P, Van Maele G, Perehudoff K, Petrovic M . Evaluation of clinical pharmacist recommendations in the geriatric ward of a Belgian university hospital. Clin Interv Aging. 2013; 8:703-9. PMC: 3686245. DOI: 10.2147/CIA.S42162. View

Samsa G, Hanlon J, Schmader K, Weinberger M, Clipp E, Uttech K . A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol. 1994; 47(8):891-6. DOI: 10.1016/0895-4356(94)90192-9. View

Howe J, Lindsey L . The role of pharmacists in supporting service users to optimise antipsychotic medication. Int J Clin Pharm. 2023; 45(5):1293-1298. PMC: 10600309. DOI: 10.1007/s11096-023-01630-9. View

Gladigau E, Fazio T, Hannam J, Dawson L, Jones S . Increased cardiovascular risk in patients with severe mental illness. Intern Med J. 2014; 44(1):65-9. DOI: 10.1111/imj.12319. View

Skapinakis P, Politis S, Karampas A, Petrikis P, Mavreas V . Prevalence, comorbidity, quality of life and use of services of obsessive-compulsive disorder and subthreshold obsessive-compulsive symptoms in the general adult population of Greece. Int J Psychiatry Clin Pract. 2019; 23(3):215-224. DOI: 10.1080/13651501.2019.1588327. View

Mitchell A, Lord O, Malone D . Differences in the prescribing of medication for physical disorders in individuals with v. without mental illness: meta-analysis. Br J Psychiatry. 2012; 201(6):435-43. DOI: 10.1192/bjp.bp.111.094532. View

Gervaix J, Haour G, Michel M, Chevreul K . Impact of mental illness on care for somatic comorbidities in France: a nation-wide hospital-based observational study. Epidemiol Psychiatr Sci. 2018; 28(5):495-507. PMC: 6999027. DOI: 10.1017/S2045796018000203. View

Dawoud D, Smyth M, Ashe J, Strong T, Wonderling D, Hill J . Effectiveness and cost effectiveness of pharmacist input at the ward level: a systematic review and meta-analysis. Res Social Adm Pharm. 2018; 15(10):1212-1222. DOI: 10.1016/j.sapharm.2018.10.006. View

Haussleiter I, Emons B, Hoffmann K, Juckel G . The somatic care situation of people with mental illness. Health Sci Rep. 2020; 4(1):e226. PMC: 7752157. DOI: 10.1002/hsr2.226. View

10.

Ruggeri M, Leese M, Thornicroft G, Bisoffi G, Tansella M . Definition and prevalence of severe and persistent mental illness. Br J Psychiatry. 2000; 177:149-55. DOI: 10.1192/bjp.177.2.149. View

11.

Kohn L, Christiaens W, Detraux J, De Lepeleire J, De Hert M, Gillain B . Barriers to Somatic Health Care for Persons With Severe Mental Illness in Belgium: A Qualitative Study of Patients' and Healthcare Professionals' Perspectives. Front Psychiatry. 2022; 12:798530. PMC: 8825501. DOI: 10.3389/fpsyt.2021.798530. View

12.

Schultz B, Tilton J, Jun J, Scott-Horton T, Quach D, Touchette D . Cost-Effectiveness Analysis of a Pharmacist-Led Medication Therapy Management Program: Hypertension Management. Value Health. 2021; 24(4):522-529. DOI: 10.1016/j.jval.2020.10.008. View

13.

Eaves S, Gonzalvo J, Hamm J, Williams G, Ott C . The evolving role of the pharmacist for individuals with serious mental illness. J Am Pharm Assoc (2003). 2020; 60(5S):S11-S14. DOI: 10.1016/j.japh.2020.04.017. View

14.

Grimes T, Deasy E, Allen A, OByrne J, Delaney T, Barragry J . Collaborative pharmaceutical care in an Irish hospital: uncontrolled before-after study. BMJ Qual Saf. 2014; 23(7):574-83. PMC: 4078714. DOI: 10.1136/bmjqs-2013-002188. View

15.

Katsikidou M, Samakouri M, Fotiadou M, Arvaniti A, Vorvolakos T, Xenitidis K . Victimization of the severely mentally ill in Greece: the extent of the problem. Int J Soc Psychiatry. 2012; 59(7):706-15. DOI: 10.1177/0020764012448782. View

16.

Sadowski C, Charrois T, Sehn E, Chatterley T, Kim S . The role and impact of the pharmacist in long-term care settings: A systematic review. J Am Pharm Assoc (2003). 2020; 60(3):516-524.e2. DOI: 10.1016/j.japh.2019.11.014. View

17.

Porfyri G, Athanasiadou M, Siokas V, Giannoglou S, Skarpari S, Kikis M . Mental health-related stigma discrimination and prejudices among Greek healthcare professionals. Front Psychiatry. 2022; 13:1027304. PMC: 9757138. DOI: 10.3389/fpsyt.2022.1027304. View

18.

Porfyri G, Athanasiadou M, Siokas V, Angelopoulos K, Skarpari S, Zagalioti S . Mental illness through the perspective of undergraduate medical students in Greece: a cross-sectional study at Aristotle University of Thessaloniki. Front Psychiatry. 2023; 14:1228539. PMC: 10646174. DOI: 10.3389/fpsyt.2023.1228539. View

19.

Stylianidis S, Pantelidou S, Chondros P, Roelandt J, Barbato A . Prevalence of mental disorders in a Greek island. Psychiatriki. 2014; 25(1):19-26. View

20.

Hanlon J, Schmader K, Ruby C, Weinberger M . Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc. 2001; 49(2):200-9. DOI: 10.1046/j.1532-5415.2001.49042.x. View